​

Ocular Therapeutix (OCUL) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Ocular Therapeutix Revenue Highlights

Latest Revenue (Y)

$58.44M

Latest Revenue (Q)

$14.71M

Main Segment (Y)

Product revenue, net

Ocular Therapeutix Revenue by Period

Ocular Therapeutix Revenue by Year

DateRevenueChange
2023-12-31$58.44M13.49%
2022-12-31$51.49M18.32%
2021-12-31$43.52M150.08%
2020-12-31$17.40M311.71%
2019-12-31$4.23M112.41%
2018-12-31$1.99M3.48%
2017-12-31$1.92M1.91%
2016-12-31$1.89M7.83%
2015-12-31$1.75M126.68%
2014-12-31$772.00K100.00%
2013-12-31--100.00%
2012-12-31$10.00K-

Ocular Therapeutix generated $58.44M in revenue during NA 2023, up 13.49% compared to the previous quarter, and up 2936.83% compared to the same period a year ago.

Ocular Therapeutix Revenue by Quarter

DateRevenueChange
2024-03-31$14.71M-0.59%
2023-12-31$14.80M-0.99%
2023-09-30$14.95M-1.55%
2023-06-30$15.19M13.55%
2023-03-31$13.37M-4.99%
2022-12-31$14.08M17.64%
2022-09-30$11.96M-2.45%
2022-06-30$12.27M-6.98%
2022-03-31$13.19M7.14%
2021-12-31$12.31M1.28%
2021-09-30$12.15M3.71%
2021-06-30$11.72M59.60%
2021-03-31$7.34M-0.10%
2020-12-31$7.35M25.07%
2020-09-30$5.88M274.51%
2020-06-30$1.57M-39.86%
2020-03-31$2.61M15.65%
2019-12-31$2.26M172.14%
2019-09-30$829.00K27.54%
2019-06-30$650.00K32.11%
2019-03-31$492.00K-2.38%
2018-12-31$504.00K1.20%
2018-09-30$498.00K-23.15%
2018-06-30$648.00K90.59%
2018-03-31$340.00K-30.18%
2017-12-31$487.00K-6.88%
2017-09-30$523.00K19.41%
2017-06-30$438.00K-7.79%
2017-03-31$475.00K-7.05%
2016-12-31$511.00K7.13%
2016-09-30$477.00K8.16%
2016-06-30$441.00K-3.71%
2016-03-31$458.00K5.05%
2015-12-31$436.00K1.63%
2015-09-30$429.00K-6.54%
2015-06-30$459.00K7.75%
2015-03-31$426.00K-15.64%
2014-12-31$505.00K253.15%
2014-09-30$143.00K47.42%
2014-06-30$97.00K259.26%
2014-03-31$27.00K100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30-100.00%
2013-03-31--

Ocular Therapeutix generated $14.71M in revenue during Q1 2024, up -0.59% compared to the previous quarter, and up 104.54% compared to the same period a year ago.

Ocular Therapeutix Revenue Breakdown

Ocular Therapeutix Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 18
Collaboration revenue$573.00K$1.04M-
Product revenue, net$57.87M--
Product-$50.46M$1.99M

Ocular Therapeutix's latest annual revenue breakdown by segment (product or service), as of Dec 23: Product revenue, net (99.02%), and Collaboration revenue (0.98%).

Quarterly Revenue by Product

Product/ServiceSep 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 18Sep 18Jun 18Mar 18
Collaboration revenue$78.00K$59.00K$125.00K$131.00K$157.00K$160.00K$173.00K$52.00K$122.00K$689.00K----
Product revenue, net$15.35M$14.71M$42.92M$14.95M----------
Product----$15.03M$13.21M$13.90M$11.91M$12.14M$12.50M$504.00K$498.00K$648.00K$340.00K

Ocular Therapeutix's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Product revenue, net (99.49%), and Collaboration revenue (0.51%).

Ocular Therapeutix Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
AMLXAmylyx Pharmaceuticals$380.79M$416.00K
CTMXCytomX Therapeutics$101.21M$33.43M
SPROSpero Therapeutics$96.73M$13.47M
OCULOcular Therapeutix$58.44M$14.71M
HOOKHOOKIPA Pharma$20.13M-
MREOMereo BioPharma Group$10.00M-
ASMBAssembly Biosciences$7.16M$6.84M
XFORX4 Pharmaceuticals-$560.00K
PDSBPDS Bio--
DAWNDay One Biopharmaceuticals-$20.07M
ABOSAcumen Pharmaceuticals--
INZYInozyme Pharma--
TERNTerns Pharmaceuticals--
ACHLAchilles Therapeutics--

OCUL Revenue FAQ

What is Ocular Therapeutix’s yearly revenue?

Ocular Therapeutix's yearly revenue for 2023 was $58.44M, representing an increase of 13.49% compared to 2022. The company's yearly revenue for 2022 was $51.49M, representing an increase of 18.32% compared to 2021. OCUL's yearly revenue for 2021 was $43.52M, representing an increase of 150.08% compared to 2020.

What is Ocular Therapeutix’s quarterly revenue?

Ocular Therapeutix's quarterly revenue for Q1 2024 was $14.72M, a -0.59% decrease from the previous quarter (Q4 2023), and a 10.03% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $14.8M, a -0.99% decrease from the previous quarter (Q3 2023), and a 5.16% increase year-over-year (Q4 2022). OCUL's quarterly revenue for Q3 2023 was $14.95M, a -1.55% decrease from the previous quarter (Q2 2023), and a 24.95% increase year-over-year (Q3 2022).

What is Ocular Therapeutix’s revenue growth rate?

Ocular Therapeutix's revenue growth rate for the last 3 years (2021-2023) was 34.28%, and for the last 5 years (2019-2023) was 1282.61%.

What are Ocular Therapeutix’s revenue streams?

Ocular Therapeutix's revenue streams in c 23 are Collaboration revenue, and Product revenue, net. Collaboration revenue generated $573K in revenue, accounting 0.98% of the company's total revenue, down -44.74% year-over-year. Product revenue, net generated $57.87M in revenue, accounting 99.02% of the company's total revenue

What is Ocular Therapeutix’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Ocular Therapeutix was Product revenue, net. This segment made a revenue of $57.87M, representing 99.02% of the company's total revenue.